United States · FDA National Drug Code directory
KOSELUGO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-0625_bdebc47d-8420-42eb-aaa7-b243dc9e42b2
- Product NDC
- 0310-0625
- Form
- CAPSULE
- Composition / generic term
- SELUMETINIB
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200416
- Source listing expiry
- 20271231
Source-listed ingredients
- SELUMETINIB — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 CAPSULE in 1 BOTTLE (0310-0625-28) · 0310-0625-28
- 60 CAPSULE in 1 BOTTLE (0310-0625-60) · 0310-0625-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →